Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 173

1.

Prognostic significance of prospectively detected bone marrow micrometastases in esophagogastric cancer: 10-year follow-up confirms prognostic significance.

Ryan P, Furlong H, Murphy CG, O'Sullivan F, Walsh TN, Shanahan F, O'Sullivan GC.

Cancer Med. 2015 Apr 27. doi: 10.1002/cam4.470. [Epub ahead of print]

2.

Oral tolerance to cancer can be abrogated by T regulatory cell inhibition.

Whelan MC, Casey G, Larkin JO, Guinn BA, O'Sullivan GC, Tangney M.

PLoS One. 2014 May 15;9(5):e97602. doi: 10.1371/journal.pone.0097602. eCollection 2014.

3.

An objective evaluation of a multi-component, competitive, selection process for admitting surgeons into higher surgical training in a national setting.

Gallagher AG, O'Sullivan GC, Neary PC, Carroll SM, Leonard G, Bunting BP, Traynor O.

World J Surg. 2014 Feb;38(2):296-304. doi: 10.1007/s00268-013-2302-4.

PMID:
24146198
4.

Attentional capacity: an essential aspect of surgeon performance.

Gallagher AG, Satava RM, OʼSullivan GC.

Ann Surg. 2015 Mar;261(3):e60-1. doi: 10.1097/SLA.0b013e318296c473. No abstract available.

PMID:
23732269
5.

Adenovirus-mediated transcriptional targeting of colorectal cancer and effects on treatment-resistant hypoxic cells.

Rajendran S, O'Sullivan GC, O'Hanlon D, Tangney M.

Clin Colorectal Cancer. 2013 Sep;12(3):152-162.e1. doi: 10.1016/j.clcc.2012.11.005. Epub 2013 Jan 10.

PMID:
23313233
6.

Objective structured assessment of technical skills and checklist scales reliability compared for high stakes assessments.

Gallagher AG, O'Sullivan GC, Leonard G, Bunting BP, McGlade KJ.

ANZ J Surg. 2014 Jul-Aug;84(7-8):568-73. doi: 10.1111/j.1445-2197.2012.06236.x. Epub 2012 Sep 3.

PMID:
22943748
7.

Laparoscopic lavage for perforated diverticulitis: a population analysis.

Rogers AC, Collins D, O'Sullivan GC, Winter DC.

Dis Colon Rectum. 2012 Sep;55(9):932-8. doi: 10.1097/DCR.0b013e31826178d0.

PMID:
22874599
8.

Control and augmentation of long-term plasmid transgene expression in vivo in murine muscle tissue and ex vivo in patient mesenchymal tissue.

Morrissey D, van Pijkeren JP, Rajendran S, Collins SA, Casey G, O'Sullivan GC, Tangney M.

J Biomed Biotechnol. 2012;2012:379845. doi: 10.1155/2012/379845. Epub 2012 Jul 1.

9.

Prospective, randomized assessment of the acquisition, maintenance, and loss of laparoscopic skills.

Gallagher AG, Jordan-Black JA, O'Sullivan GC.

Ann Surg. 2012 Aug;256(2):387-93. doi: 10.1097/SLA.0b013e318251f3d2.

PMID:
22580935
10.

High resolution in vivo bioluminescent imaging for the study of bacterial tumour targeting.

Cronin M, Akin AR, Collins SA, Meganck J, Kim JB, Baban CK, Joyce SA, van Dam GM, Zhang N, van Sinderen D, O'Sullivan GC, Kasahara N, Gahan CG, Francis KP, Tangney M.

PLoS One. 2012;7(1):e30940. doi: 10.1371/journal.pone.0030940. Epub 2012 Jan 25.

11.

The BH3 mimetic HA14-1 enhances 5-fluorouracil-induced autophagy and type II cell death in oesophageal cancer cells.

Nyhan MJ, O'Donovan TR, Elzinga B, Crowley LC, O'Sullivan GC, McKenna SL.

Br J Cancer. 2012 Feb 14;106(4):711-8. doi: 10.1038/bjc.2011.604. Epub 2012 Jan 12.

12.

Deficits in surgical technical performance: prolonged effects of alcohol.

O'Sullivan GC, Kearney PP, Lönn L, McGlade K.

Arch Surg. 2011 Dec;146(12):1452. doi: 10.1001/archsurg.2011.999. No abstract available.

PMID:
22184315
13.

Targeting regulatory T cells in cancer.

Byrne WL, Mills KH, Lederer JA, O'Sullivan GC.

Cancer Res. 2011 Nov 15;71(22):6915-20. doi: 10.1158/0008-5472.CAN-11-1156. Epub 2011 Nov 8. Review.

14.

Induction of effective antitumor response after mucosal bacterial vector mediated DNA vaccination with endogenous prostate cancer specific antigen.

Ahmad S, Casey G, Cronin M, Rajendran S, Sweeney P, Tangney M, O'Sullivan GC.

J Urol. 2011 Aug;186(2):687-93. doi: 10.1016/j.juro.2011.03.139. Epub 2011 Jun 17.

PMID:
21683415
15.

Targeting of breast metastases using a viral gene vector with tumour-selective transcription.

Rajendran S, Collins S, van Pijkeren JP, O'Hanlon D, O'Sullivan GC, Tangney M.

Anticancer Res. 2011 May;31(5):1627-35.

PMID:
21617219
16.

VHL genetic alteration in CCRCC does not determine de-regulation of HIF, CAIX, hnRNP A2/B1 and osteopontin.

Nyhan MJ, El Mashad SM, O'Donovan TR, Ahmad S, Collins C, Sweeney P, Rogers E, O'Sullivan GC, McKenna SL.

Cell Oncol (Dordr). 2011 Jun;34(3):225-34. doi: 10.1007/s13402-011-0029-5. Epub 2011 May 6.

PMID:
21547579
17.

Bacteria as vectors for gene therapy of cancer.

Baban CK, Cronin M, O'Hanlon D, O'Sullivan GC, Tangney M.

Bioeng Bugs. 2010 Nov-Dec;1(6):385-94. doi: 10.4161/bbug.1.6.13146. Review.

18.

Preclinical evaluation of gene delivery methods for the treatment of loco-regional disease in breast cancer.

Rajendran S, O'Hanlon D, Morrissey D, O'Donovan T, O'Sullivan GC, Tangney M.

Exp Biol Med (Maywood). 2011 Apr 1;236(4):423-34. doi: 10.1258/ebm.2011.010234. Epub 2011 Mar 28.

PMID:
21444371
19.

Can non-viral technologies knockdown the barriers to siRNA delivery and achieve the next generation of cancer therapeutics?

Guo J, Bourre L, Soden DM, O'Sullivan GC, O'Driscoll C.

Biotechnol Adv. 2011 Jul-Aug;29(4):402-17. doi: 10.1016/j.biotechadv.2011.03.003. Epub 2011 Mar 22. Review.

PMID:
21435387
20.

Ex vivo culture of patient tissue & examination of gene delivery.

Rajendran S, Salwa S, Gao X, Tabirca S, O'Hanlon D, O'Sullivan GC, Tangney M.

J Vis Exp. 2010 Dec 20;(46). pii: 2378. doi: 10.3791/2378.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk